Evidence map›Paper›PMID 26792290›Full record

ArticleEuropean journal of pediatrics2016

Aminoglycoside use in a pediatric hospital: there is room for improvement-a before/after study.

Mélanie Houot, Benoit Pilmis, Valérie Thepot-Seegers, Clémence Suard, Cyrielle Potier, Martine Postaire, Jean-Ralph Zahar

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Impact of pharmacist-led aminoglycoside stewardship: a 10-year observational study.Journal of pharmaceutical health care and sciences · 2024
    Article
  2. Article
  3. Application of guidelines for aminoglycosides use in French hospitals in 2013-2014.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mélanie HouotPharmacy Department, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France.
Benoit PilmisInfection Control Unit, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France.
Valérie Thepot-SeegersCellular Interactions and Therapeutic Applications Department, CHU Angers, 49933, Angers Cedex 9, France.
Clémence SuardPharmacy Department, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France.
Cyrielle PotierPharmacy Department, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France.
Martine PostairePharmacy Department, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France.
Jean-Ralph ZaharInfection Control Unit, CHU Necker-Enfants Malades, 149 rue de Sèvres, Paris, France. JeanRalph.Zahar@chu-angers.fr.
Hôpital Necker-Enfants Malades · FRCentre Hospitalier Universitaire d'Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledAminoglycoside prescriptions were rarely evaluated in children care facilities. Because of risk of toxicity, these narrow spectrum antibiotics are commonly misused. In this study, we evaluate aminoglycoside prescription and assess the impact of an information campaign on modalities of prescription and monitoring practices in a pediatric hospital. This prospective study, before/after diffusion of local recommendations, has been conducted over 6 months. All computerized prescriptions were analyzed. A semi-passive diffusion of local recommendations to prescribers allowed researchers to differentiate between a pre-intervention (P1) and post-intervention period (P2). Endpoints were the improvement of administered doses (mg/kg), modalities of administration, treatment duration, indications, and the presence of pharmacological monitoring. Three hundred and ten prescriptions were analyzed (P1 = 163, P2 = 147). Most common sites of infection treated were as follows: joint-bone (33 %), urinary tract (17 %) and intra-abdominal (15 %). Among all prescriptions, respectively, 12 and 13 % were avoidable. Short-duration treatment and single daily dosing seem to be widely achieved, but despite an improvement between the two periods, 45 % of prescribed doses in P2 were still below our recommendations (77 % in P1).

conclusionThe semi-passive diffusion of recommendations has not improved significantly medical practices. Active diffusion with a regular monitoring could be useful to improve the use of aminoglycosides. WHAT IS KNOWN: • Misuse of aminoglycosides has been frequently described and evaluated in adult hospitals. • This misuse could be explained by their nephrotoxicity and their low therapeutic index. What is New: • Through this study, conducted in a pediatric hospital, we highlighted that practitioners misunderstand the aminoglycoside pharmacokinetic and pharmacodynamic targets and 12.3 % of aminoglycoside prescriptions could be avoided. • Finally, we showed that a semi-passive diffusion of local recommendations is not enough to improve aminoglycoside prescriptions.

Indexed as

Clinical AuditHospitals, PediatricAminoglycosidesChildDrug PrescriptionsFemaleFollow-Up StudiesHumansMaleProspective StudiesTime FactorsAminoglycosidesAminoglycosidesAuditInformation campaignPediatrics

Identifiers

PMID26792290
OpenAlexW2285846212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.